Telmisartan at 80 mg/Day Increases High-Molecular-Weight Adiponectin Levels and Improves Insulin Resistance in Diabetic Patients.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Works matching IS 0741238X AND DT 2012 AND VI 29 AND IP 7
Results: 10
1
2
Comparison of Tacrolimus, Fluorometholone, and Saline in Mild-to-Moderate Contact Lens-Induced Papillary Conjunctivitis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
3
Diquafosol ophthalmic solution for dry eye treatment.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
4
Evolution of insulin development: focus on key parameters.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
5
Cost per responder associated with biologic therapies for Crohn's disease, psoriasis, and rheumatoid arthritis.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
6
Telmisartan at 80 mg/Day Increases High-Molecular-Weight Adiponectin Levels and Improves Insulin Resistance in Diabetic Patients.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 7, p. 635, doi. 10.1007/s12325-012-0032-x
- By:
- Publication type:
- Article
7
Comparison of Tacrolimus, Fluorometholone, and Saline in Mild-to-Moderate Contact Lens-Induced Papillary Conjunctivitis.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 7, p. 645, doi. 10.1007/s12325-012-0031-y
- By:
- Publication type:
- Article
8
Cost Per Responder Associated with Biologic Therapies for Crohn's Disease, Psoriasis, and Rheumatoid Arthritis.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 7, p. 620, doi. 10.1007/s12325-012-0035-7
- By:
- Publication type:
- Article
9
Evolution of Insulin Development: Focus on Key Parameters.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 7, p. 590, doi. 10.1007/s12325-012-0034-8
- By:
- Publication type:
- Article
10
Diquafosol Ophthalmic Solution for Dry Eye Treatment.
- Published in:
- Advances in Therapy, 2012, v. 29, n. 7, p. 579, doi. 10.1007/s12325-012-0033-9
- By:
- Publication type:
- Article